review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1093/RHEUMATOLOGY/KEN477 |
P698 | PubMed publication ID | 19153144 |
P50 | author | Janet Pope | Q48742471 |
P2093 | author name string | Kim Baker | |
P2860 | cites work | Quantifying heterogeneity in a meta-analysis | Q27860672 |
Meta-analysis in clinical trials | Q27860779 | ||
Work dynamics among persons with systemic lupus erythematosus | Q33871651 | ||
Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability | Q35638310 | ||
Measurement of fatigue in systemic lupus erythematosus: a systematic review | Q37020357 | ||
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort | Q37137321 | ||
Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus | Q40573631 | ||
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality | Q44795825 | ||
Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaire | Q50146708 | ||
Total costs and predictors of costs in patients with systemic lupus erythematosus. | Q50669701 | ||
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. | Q50803898 | ||
Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. | Q51920376 | ||
P433 | issue | 3 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
disability | Q12131 | ||
systematic review | Q1504425 | ||
P304 | page(s) | 281-284 | |
P577 | publication date | 2009-01-19 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | Employment and work disability in systemic lupus erythematosus: a systematic review | |
P478 | volume | 48 |
Q35816153 | Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis |
Q38968818 | Burden of lupus on work: Issues in the employment of individuals with lupus |
Q38416827 | Capturing complexity in work disability research: application of system dynamics modeling methodology |
Q47193610 | Cognitive functioning in systemic lupus erythematosus: a meta-analysis |
Q48618855 | Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients |
Q55214707 | Cultural and quality-of-life considerations when administering corticosteroids as a therapeutic strategy for African American women living with systemic lupus erythematosus. |
Q30248866 | Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events |
Q34267149 | Data quality challenges in systemic lupus erythematosus trials: how can this be optimized? |
Q55234314 | Definition of NPSLE: Does the ACR Nomenclature Still Hold? |
Q35156880 | Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort |
Q46496211 | Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes |
Q34424649 | Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study |
Q36411744 | Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) f |
Q33708268 | Health-related quality of life and employment among persons with systemic lupus erythematosus |
Q47650187 | Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus |
Q88062932 | Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007 |
Q35243135 | Impact of obesity on functioning among women with systemic lupus erythematosus |
Q48192370 | Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States |
Q35998043 | Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus |
Q41544586 | Job Accommodations Availability and Utilization Among People With Lupus: An Examination of Workplace Activity Limitations and Work Context Factors |
Q34234020 | Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus. |
Q57461365 | Long-term impact of belimumab on health-related quality of life and fatigue in patients with systemic lupus erythematosus: 6 years of treatment |
Q35686616 | Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus |
Q45183938 | Lupus and community-based social work |
Q39257920 | Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. |
Q37922765 | Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management |
Q34351248 | Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review |
Q47292875 | Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry |
Q47724375 | Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases. |
Q39287162 | Psychosocial impact of mast cell disorders: Pilot investigation of a rare and understudied disease |
Q55006497 | Self-care agency in systemic lupus erythematosus and its associated factors: a cross-sectional study. |
Q38858733 | Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus. |
Q50848358 | Systemic lupus erythematosus. |
Q36112610 | The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort |
Q37800303 | The economic burden of systemic lupus erythematosus in Asia: the current state |
Q38936647 | The global burden of SLE: prevalence, health disparities and socioeconomic impact |
Q37978906 | The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects. |
Q37309687 | The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey |
Q40957928 | Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort |
Q58785147 | Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices |
Q39150632 | Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. |
Q35848834 | Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: a pilot study |
Q37985709 | What do we know about self-reported fatigue in systemic lupus erythematosus? |
Q44362369 | Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors |
Q35008185 | Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus |
Q44382733 | Work factors are associated with workplace activity limitations in systemic lupus erythematosus |
Q92526957 | Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey |
Search more.